[1] McCrindle BW, Rowley AH, Newburger JW. et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017 Apr 25;135(17):e927-e999.
[2] Singh S, Jindal AK, Pilania RK. Diagnosis of Kawasaki disease. Int J Rheum Dis. 2018 Jan; 21(1): 36-44.
[3] Rossi M, Siani P, Grossi A, et al. Aseptic meningitis as onset of Kawasaki disease. Minerva Pediatr. 2019 Jan 17. [Epub ahead of print]
[4] Türel O, Güzeltaş A, Aydoğmuş C. Kawasaki disease presenting as meningitis in a two months old infant. Anadolu Kardiyol Derg. 2011 Jun; 11(4): 369-70.
[5] Dengler LD, Capparelli EV, Bastian, et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J. 1998 Jun;17(6):478-81.
[6] Yeom JS, Park JS, Seo JH, et al. Initial characteristics of Kawasaki disease with cerebrospinal fluid pleocytosis in febrile infants. Pediatr Neurol. 2012 Oct;47(4):259-62.
[7] Yasushi K, Tomotaka N, Hiroyuki M, et al. Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease[J]. Pediatr Rheumatolon Online, 2011, 9(1):28-28.
[8] Cho A R, Park J Y, Kim K H, et al. Aseptic Meningitis Secondary to High-Dose Intravenous Immunoglobulin Therapy in Kawasaki Disease[J]. Korean Journal of Pediatrics, 2004, 47(5).
[9] Peng Y , Liu X , Duan Z , et al. Prevalence and characteristics of arthritis in Kawasaki disease: a Chinese cohort study[J]. Clinical and Experimental Medicine, 2019.
[10] Zhang Y, Wan H, Du M, et al. Capillary leak syndrome and aseptic meningitis in a patient with Kawasaki disease: A case report[J]. Medicine, 2018, 97(23):e10716.
[11] Ohnishi Y, Mori, Kazuhiro, Inoue, Miki, et al. A case of Kawasaki disease presenting as sigmoid colitis[J]. Journal of Medical Ultrasonics, 2017, 45(2):1-4.
[12] Eleftheriou D, Levin M, Shingadia D et al. Management of Kawasaki disease. Arch Dis Child 2014;99:74_83.
[13] Vasilopoulou VA, Karanika M, Theodoridou K, Katsioulis AT, Theodoridou MN, Hadjichristodoulou CS. Prognostic factors related to sequelae in childhood bacterial meningitis: data from a Greek meningitis registry. BMC Infect Dis 2011;11:214.
[14] Snaebjarnardottir K, Erlendsdottir H, Reynisson IK, Kristinsson K, Halldórsdóttir S, Hardardóttir H, et al. Bacterial meningitis in children in Iceland, 1975–2010: a nationwide epidemiological study. Scand J Infect Dis 2013;45:819–24.
[15] Franco-Paredes C, Lammoglia L, Hernandez I, Santos-Preciado JI. Epidemiology and outcomes of bacterial meningitis in Mexican children: 10-year experience (1993–2003). Int J Infect Dis 2008;12: 380–6.
[16] Cabral M , Correia P , Maria João Brito, et al. Kawasaki disease in a young infant: Diagnostic challenges[J]. Acta reumatologica portuguesa, 2011, 36(3):304-308.
[17] Husain E , Hoque E . Meningoencephalitis as a Presentation of Kawasaki Disease[J]. Journal of Child Neurology, 2006, 21(12):1080-1081.
[18] De Graeff N , Groot N , Ozen S , et al. European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease – the SHARE initiative[J]. Rheumatology, 2018.
[19] Huang MY, Gupta-Malhotra M, Huang JJ, Syu FK, Huang TY. Acutephase reactants and a supplemental diagnostic aid for Kawasaki disease. Pediatr Cardiol 2010;31:1209e13.
[20] Van Ettekoven C , Diederik V D B , Brouwer M C . Update on Community-acquired bacterial meningitis: Guidance and challenges[J]. Clinical Microbiology and Infection, 2017:S1198743X17302306.
[21] Lars L , Anna-Karin P , Gunnar J , et al. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis[J]. PLOS ONE, 2017, 12(7):e0181704.